Heska Corp. (Restricted Voting)
HSKA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.31B
Close$
$142.31
18.6% upside
Current Fair Value
18.6% upsideUndervalued by 18.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.31 Billion |
|---|---|
| Enterprise Value | $1.30 Billion |
| Dividend Yield | $0.30 (-) |
| Earnings per Share | $-1.78 |
| Beta | 1.6 |
| Outstanding Shares | 10,390,000 |
Return
| Return on Equity | -4.71% |
|---|---|
| Return on Assets | -3.32% |
| Return on Invested Capital | -3.48% |
Valuation & Multiples
| P/E Ratio | -67.36 |
|---|---|
| PEG | 3203.17 |
| Price to Sales | 5.0 |
| Price to Book Ratio | 3.0 |
| Enterprise Value to Revenue | 5.1 |
| Enterprise Value to EBIT | -67.86 |
| Enterprise Value to Net Income | -67 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Heska Corp.
CEO: Kevin Wilson Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instr...